IQVIA Gets CDSCO Panel Nod To Study AVT06 biosimilar candidate to Eylea Dr. Divya Colin9 Oct 2022 1:40 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to the...
Bayer, Regeneron anti-blindness drug Eylea shown to work at higher dose, longer intervals Ruchika Sharma11 Sept 2022 9:00 AM ISTFrankfurt: Bayer said on Thursday that its anti-blindness treatment Eylea, jointly developed with Regeneron, was shown to work as well when given...
Lupin, DKSH ink pact to commercialize 5 of Alvotech proposed biosimilars in Philippines Ruchika Sharma7 Sept 2022 11:45 AM ISTThis agreement enhances Multicare's oncology, rheumatology, gastroenterology, and ophthalmology, portfolio, which currently consists of three...
Shilpa Biologicals gets NoC to conduct trials of biosimilar Aflibercept Ruchika Sharma26 April 2022 3:55 PM ISTBiosimilar Aflibercept is the second biosimilar product from SML that has entered the clinical trial phase after Biosimilar Adalimumab.
Cipla Gulf expands partnership with Alvotech for commercialization of 4 biosimilar medicines in Australia, New Zealand Ruchika Sharma2 March 2021 4:26 PM ISTMumbai: Cipla Limited today announced that the company's subsidiary, Cipla Gulf FZ LCC ("Cipla Gulf') is expanding its partnership with Alvotech for...
